Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate

Diabetologia

Volumn 61, Issue 1, 2018, Pages 101-107

  Hulman, Adam ^a,b,c   Vistisen, Dorte ^d   Glümer, Charlotte ^e   Bergman, Michael ^f   Witte, Daniel R ^a,b   Færch, Kristine ^d  

^a AARHUS UNIVERSITY   (Denmark)

^b DANISH DIABETES ACADEMY   (Denmark)

^c UNIVERSITY OF SZEGED   (Hungary)

^d STENO DIABETES CENTER   (Denmark)

^e GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

30 minute post OGTT glucose; Cardiovascular disease; Latent class modelling; Mortality; Oral glucose tolerance test; Plasma glucose curve; Type 2 diabetes

Indexed keywords

GLUCOSE; HEXOKINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALL CAUSE MORTALITY; ARTICLE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CELL HETEROGENEITY; CLINICAL EXAMINATION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TIME TO TREATMENT; BLOOD; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PROPORTIONAL HAZARDS MODEL;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FASTING; GLUCOSE TOLERANCE TEST; HUMANS; PROPORTIONAL HAZARDS MODELS;

EID: 85030692166     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-017-4468-z     Document Type: Article

References (21)

1. World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF Consultation. Available from www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf. Accessed 21 Sep 2017
2. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M (2007) What is the best predictor of future type 2 diabetes? Diabetes Care 30:1544–1548
3. Alyass A, Almgren P, Akerlund M et al (2015) Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts. Diabetologia 58:87–97
4. Jagannathan R, Sevick MA, Li H et al (2016) Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study from a real world health care setting. Endocrine 52:172–175
5. Bergman M, Chetrit A, Roth J, Dankner R (2015) Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension. Diabetes Metab Res Rev 31:368–375
6. Abdul-Ghani MA, Lyssenko V, Tuomi T, Defronzo RA, Groop L (2010) The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes. Diabetes Metab Res Rev 26:280–286
7. Kanauchi M, Kimura K, Kanauchi K, Saito Y (2005) Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals. Int J Clin Pract 59:427–432
8. 1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes. PLoS One 9:e109506
9. Bergman M, Chetrit A, Roth J, Dankner R (2016) One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension. Diabet Med 33:1060–1066
10. Hulman A, Simmons RK, Vistisen D et al (2017) Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk. Endocrine 55:427–434
11. Hulman A, Gujral UP, Narayan KMV et al (2017) Glucose patterns during the OGTT and risk of future diabetes in an urban Indian population: the CARRS study. Diabetes Res Clin Pract 126:192–197
12. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, Pisinger C (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 10:377–386
13. Cederholm J, Wibell L (1990) Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 10:167–175
14. 0, 120: comparison with other measures. Diabetes Res Clin Pract 47:177–184
15. Seltzer HS, Allen EW, Herron AL Jr, Brennan MT (1967) Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46:323–335
16. Carstensen B, Kristensen JK, Marcussen MM, Borch-Johnsen K (2011) The National Diabetes Register. Scand J Public Health 39:58–61
17. Helweg-Larsen K (2011) The Danish Register of causes of death. Scand J Public Health 39:26–29
18. Lynge E, Sandegaard JL, Rebolj M (2011) The Danish National Patient Register. Scand J Public Health 39:30–33
19. Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB Sr, Wilson PW (2005) Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 54:3252–3257
20. Zethelius B, Cederholm J (2015) Comparison between indexes of insulin resistance for risk prediction of cardiovascular diseases or development of diabetes. Diabetes Res Clin Pract 110:183–192
21. 1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis. Diabetologia 57:30–39